News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
852,786 Results
Type
Article (86870)
Company Profile (704)
Press Release (765210)
Multimedia
Podcasts (145)
Webinars (19)
Section
Business (232815)
Career Advice (4132)
Deals (39763)
Drug Delivery (129)
Drug Development (91107)
Employer Resources (198)
FDA (18186)
Job Trends (17363)
News (396839)
Policy (39823)
Tag
Academia (3002)
Academic (2)
Accelerated approval (11)
Adcomms (32)
Allergies (106)
Alliances (56975)
ALS (119)
Alzheimer's disease (1566)
Antibody-drug conjugate (ADC) (187)
Approvals (18136)
Artificial intelligence (396)
Autoimmune disease (37)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (135)
Biotechnology (481)
Bladder cancer (100)
Brain cancer (40)
Breast cancer (390)
Cancer (3077)
Cardiovascular disease (247)
Career advice (3540)
Career pathing (34)
CAR-T (209)
CDC (40)
Cell therapy (572)
Cervical cancer (24)
Clinical research (74296)
Collaboration (1107)
Company closure (3)
Compensation (711)
Complete response letters (33)
COVID-19 (2904)
CRISPR (67)
C-suite (351)
Cystic fibrosis (120)
Data (3072)
Decentralized trials (2)
Denatured (51)
Depression (76)
Diabetes (380)
Diagnostics (6979)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (180)
Drug pricing (152)
Drug shortages (36)
Duchenne muscular dystrophy (132)
Earnings (97504)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131459)
Executive appointments (909)
FDA (19914)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1014)
Gene editing (147)
Generative AI (39)
Gene therapy (436)
GLP-1 (934)
Government (5259)
Grass and pollen (6)
Guidances (181)
Healthcare (20917)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (184)
Immuno-oncology (10)
Indications (40)
Infectious disease (3100)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (124)
Interviews (813)
IPO (17906)
IRA (55)
Job creations (5193)
Job search strategy (2863)
Kidney cancer (15)
Labor market (56)
Layoffs (590)
Leadership (26)
Legal (10137)
Liver cancer (85)
Lung cancer (432)
Lymphoma (215)
Machine learning (11)
Management (65)
Manufacturing (440)
MASH (99)
Medical device (14724)
Medtech (14729)
Mergers & acquisitions (22576)
Metabolic disorders (964)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (142)
Neuropsychiatric disorders (41)
Neuroscience (2319)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (48)
Obesity (493)
Opinion (290)
Ovarian cancer (103)
Pain (119)
Pancreatic cancer (125)
Parkinson's disease (201)
Partnered (25)
Patents (316)
Patient recruitment (167)
Peanut (55)
People (65710)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22935)
Phase II (32259)
Phase III (24290)
Pipeline (1686)
Policy (241)
Postmarket research (3552)
Preclinical (10357)
Press Release (72)
Prostate cancer (149)
Psychedelics (45)
Radiopharmaceuticals (279)
Rare diseases (523)
Real estate (7402)
Recruiting (76)
Regulatory (27166)
Reports (61)
Research institute (2665)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (172)
Series B (118)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4304)
State (2)
Stomach cancer (17)
Supply chain (83)
Tariffs (65)
The Weekly (92)
Vaccines (917)
Venture capital (57)
Weight loss (330)
Women's health (51)
Worklife (20)
Date
Today (67)
Last 7 days (444)
Last 30 days (2028)
Last 365 days (34054)
2025 (18325)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (50529)
Australia (8878)
California (7769)
Canada (2409)
China (725)
Colorado (340)
Connecticut (346)
Delaware (205)
Europe (115922)
Florida (1154)
Georgia (263)
Hawaii (2)
Idaho (66)
Illinois (741)
India (32)
Indiana (385)
Iowa (18)
Japan (237)
Kansas (115)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1101)
Massachusetts (5949)
Michigan (275)
Minnesota (483)
Mississippi (3)
Missouri (100)
Montana (32)
Nebraska (26)
Nevada (82)
New Hampshire (73)
New Jersey (2180)
New Mexico (31)
New York (2184)
North Carolina (1245)
North Dakota (10)
Northern California (3346)
Ohio (251)
Oklahoma (17)
Oregon (48)
Pennsylvania (1660)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2872)
Tennessee (128)
Texas (1186)
United States (29351)
Utah (230)
Virginia (211)
Washington D.C. (80)
Washington State (686)
West Virginia (4)
Wisconsin (85)
There are 852,786 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
Acadia Debuts New Team, Pipeline With ‘Biotech Powerhouse’ Ambitions
More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia since last summer—are managing two products on the market and a pipeline estimated to be worth an additional $12 billion in sales.
July 15, 2025
·
5 min read
·
Heather McKenzie
Press Releases
Marea Therapeutics Presents Preclinical Data on Novel Growth Hormone Receptor Antagonist Antibody, MAR002, for the Treatment of Acromegaly at ENDO 2025
July 14, 2025
·
4 min read
Press Releases
RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p.m. ET
July 14, 2025
·
8 min read
Press Releases
Flatiron Health Research on AI-Driven Cancer Progression Extraction Presented at AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning 2025
July 14, 2025
·
3 min read
Press Releases
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
July 14, 2025
·
8 min read
Press Releases
Aviva Biopharm Inc. Unveils Groundbreaking Pre-Clinical Data on d3-T, a First-in-Class Testosterone Therapy for Women at ENDO 2025
July 14, 2025
·
3 min read
Press Releases
Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025
July 14, 2025
·
17 min read
Press Releases
Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025
July 14, 2025
·
1 min read
Press Releases
New 3-Year Phase 3 Data Confirmed Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism, Including Improvements in Biochemistries, Kidney Function, and Quality of Life
July 14, 2025
·
6 min read
Press Releases
Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society’s Annual Meeting
July 14, 2025
·
16 min read
1 of 85,279
Next
